4 Press releases

H.C. Starck inaugurates new production facility in China

Facility will produce heavy metal alloyed components for its Fabricated Products Business Group

Bayer sells H.C. Starck to Advent International and The Carlyle Group for EUR 1.2 billion

• Proceeds will help to finance the Schering acquisition • Acquirers plan expansion of H.C. Starck business • Goal is to position the company for an initial public offering in 3 to 5 years More

Allegations against H.C. Starck now also dismissed in court and by state authorities

In the course of the work of a United Nations’ panel of experts, H.C. Starck was accused of illegally purchasing raw materials from the Democratic Republic of Congo (DRC). The allegations were finally withdrawn with the UN panel’s report of 23 October 2003. In the UN final report H.C. Starck was put in the category “matter settled – no further activities necessary”.

Bayer AG announces the sale of H.C. Starck

The Bayer Group is planning to significantly strengthen its HealthCare business by acquisition. In line with this decision, the board of management has determined to offer for sale their subsidiary companies H.C. Starck and Wolff Walsrode.